Identification of a recurrent BRCA1 mutation in two breast/ovarian cancer predisposition families with distinct phenotypes, by using allele-specific multiplex-PCR;Identificarea unei mutaţii recurente BRCA1 în douǎ familii cu predispoziţie la cancer mamar/ovarian cu fenotipuri distincte, prin PCR-multiplex alelǎ-specific

Revista Romana de Medicina de Laborator

Volumn 18, Issue 2, 2010, Pages 53-61

  Negurǎ, Lucian ^a   Carasevici, Eugen ^a   Negurǎ, Anca ^b   Uhrhammer, Nancy ^c   Bignon, Yves Jean ^c  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Biochemistry and Molecular Biology Laboratory   (Romania)

^c CENTRE JEAN PERRIN   (France)

Author keywords

Allele specific multiplex PCR; BRCA recurrent mutation; Hereditary breast ovarian cancer (HBOC)

Indexed keywords

EID: 79251556610     PISSN: 18416624     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. King M.C., Marks J.H., Mandell J.B., for The New York BreastCancer Study Group, 2003, Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2. Science, 302, 643-646.
2. WHOSIS - World Health Organization Statistical Information System (http://www.who.int/whosis/en/).
3. Romanian Cancer League (http://www.romaniancancerleague.org/en/index.php).
4. Sowter H.M. and Ashworth A., 2005, BRCA1 and BRCA2 as ovarian cancer susceptibility genes. Carcinogenesis, 26(10), 1651-1656.
5. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P.A., Harshman K., Tavtigian S., Liu Q., Cochran C., Bennett L.M., Ding W. et al., 1994, A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66-71.
6. Wooster R., Neuhausen S.L., Mangion J., Quirk Y., Ford D., Collins N., Nguyen K., Seal S., Tran T., Averill D. et al., 1994, Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science, 265(5181), 2088-2090.
7. Easton D.F., Hopper J.L., Thomas D.C., Antoniou A., Pharoah P.D.P., Whittemore A. and Haile R.W., 2004, Breast cancer risks for BRCA1/2 carriers. Science, 306, 2187-2188.
8. Antoniou A. et al., 2003, Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet, 72(5), 1117-1130.
9. Breast Information Core (BIC) database (http://research.nhgri.nih.gov/bic/).
10. Walsh T., Casadei S., Coats K.H., Swisher E., Stray S.M., Higgins J., Roach K.C., Mandell J., Lee M.K., Ciernikova S., Foretova L., Soucek P. and King M.C., 2006, Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA, 295(12), 1379-1388.
11. Rahman N. and Stratton M.R., 1998, The genetics of breast cancer susceptibility. Annu Rev Genet, 32, 95-121.
12. Roa B.B., Boyd A.A., Volcik K. and Richards C.S., 1996, Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nature Genet., 14, 185-187.
13. Fitzgerald M.G. et al., 1996, Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med., 334(3), 143-149.
14. Gorski G.et al., 2000, Founder Mutations in the BRCA1 Gene in Polish Families with Breast-Ovarian Cancer. Am J Hum Genet, 66, 1963-1968.
15. Ciernikova and coll., 2006, Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families. Neoplasma, 53(2), 97-102.
16. Van der Looij and coll., 2000, Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary. Int J Cancer, 86(5), 737-740.
17. Loginova A.N. et al., 2003, Spectrum of mutations in BRCA1 gene in hereditary forms of breast and ovarian cancer in Russian families. Bull Exp Biol Med, 136(3), 276-278.
18. Ozsurek O. et al., 2001, Founder mutations in the BRCA1 gene in west Belarusian breast-ovarian cancer families. Clin Genet, 60, 470-471.
19. Chan P., Wong B., Ozcelik H. and Cole D., 1999, Simple and rapid detection of BRCA1 and BRCA2 mutations by multiplex mutagenically separated PCR. Clin Chem., 45(8), 1285-1287.
20. Human Genome Variation Society (HGVS) Nomenclature for the description of sequence variations (http://www.genomic.unimelb.edu.au/mdi/mutnomen/).
21. National Center for Biotechnology Information (NCBI) (http://www.ncbi.nlm.nih.gov/).